ArticleCancer chemotherapy and pharmacology2014

Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.

Dan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.